To test the hypothesis of the potential association of miR-146a-5p overexpression with resistance to trastuzumab, its expression was analyzed in a cohort of HER2+ BC patients’ samples from the Hospital Clínico de Valencia. This evidence concerns the gene ERBB2 and breast cancer.